ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. (RXST) (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following ...
RxSight, Inc., an ophthalmic medical device company focused on enhancing post-cataract surgery vision, will release its financial results for the fourth quarter of 2024 on February 25, 2025, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results